Bharat Biotech’s Covaxin has shown 77.8% efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III trials data on Tuesday, according to sources. The Hyderabad-based Covid vaccine manufacturing company had submitted data from the Phase III clinical trials of Covaxin to the Drugs Controller General of India (DCGI) over the … Continue reading Bharat Biotech’s Covaxin shows 77.8 % efficacy in phase 3 data trial: Sources